-
Explain the dynamics (type, economics, timing, roles) driving biotech/pharma collaborations.
-
Conceptualize novel approaches to biotech and pharma collaborations.
-
Identify key deal showstoppers from either a historical or novel transaction approach.
110 - Improving Innovation Through the Use of Social Networks (Track: Global Innovations & Markets)
Thursday, June 30, 2011
8:30 am - 9:45 am
-
Participants will appreciate how to manage risk of engaging on social networks.
-
Show how open networks may help solve big problems in innovation.
-
Explain strategic considerations necessary for social networking initiatives.
126 - The Vaccine Business Opportunity — Breakthrough Technologies for Preventing and Treating Disease (Track: Innovations in Vaccines)
Monday, June 27
3:45 pm - 5:00 pm
-
Identifying challenges and opportunities for vaccines in preventing infection and treating cancer.
-
Give the perpsective of big biotech and pharma in this field—both established and new players.
-
Describe the investor perspective on vaccines and which approaches are most likely to be funded.
141 - Safer, Faster, Cheaper: Changing Process Paradigms, Platforms and Products in Biomanufacturing (Track: Manufacturing of Biologics and Drugs)
Thursday, June 30
8:30 am - 9:45 am
-
Describe the paradigm shift from handcrafted to mature process technologies in biomanufacturing.
-
Describe how the FDA’s initiatives have sped the adoption of process methods since 1997.
-
Demonstrate how the process controls enable faster, cheaper and safer biologics.